• SCM24 will occur May 14 - 18, 2024
• NKF offers two types of registration: SCM In-Person + On-Demand and SCM On-Demand Only
• On-Demand registrants will have access to meeting content through June 27, 2024
• Abstract submissions open August 30, 2023 and close November 30, 2023
• Registration for SCM24 goes live in October 2023, with an opportunity for early-bird registration

GENERAL ABSTRACTS

General research abstracts will be accepted from August 30 through November 30, 2023, 11:59pm PT. 

Multiple research abstracts can be submitted by an individual. However, it is recommended to submit only one abstract per study. Submission of multiple abstracts on a single study may result in the rejection of one or more of the abstracts.

Abstract may be submitted in one of the below categories:

• Acute Kidney Injury/ICU Medicine
• Case Reports
• CKD/ESRD - Anemia
• CK/ESRD - Cardiovascular Disease
• CKD/ESRD - Mineral Metabolism and Kidney Stones
• CKD/ESRD - Prevalence, Progression and Preparation for Dialysis
• CKD/ESRD - Vascular Access
• CKD/ESRD - Other
• Diabetic Nephropathy
• Electrolyte and Acid Base Abnormalities
• Glomerular Diseases
• Health Policy
• Hereditary Kidney Disease/PKD
• Home Dialysis - Home Hemodialysis/Peritoneal Dialysis
• Hypertension
• Interprofessional Collaboration
• Nutrition
• Quality Improvement
• Transplantation
• Other

LATE-BREAKING ABSTRACTS

Late-breaking abstracts will be accepted from January 11 to February 1, 2024, 11:59pm PT.

Only results from major clinical trials or epidemiological studies will be considered for review.

• Processing Fee: The $60 processing fee per abstract submission is nonrefundable. The fee must be paid at the time of submission by credit card.
• Character Limit: Each abstract is limited to a maximum of 2,500 characters including title and author information. You may upload a figure in jpeg or png format which will reduce the maximum characters by 400 to 2100 characters. In addition, you may upload up to 3 supplementary files in pdf, jpeg, mp3 or mp4 format with a max size of 25 MB (online only, supplementary files will not be published in the abstract book).
• Abbreviations: Use of standard abbreviations is desirable, e.g., RBC. Use kg., gm., mg., ml., L, and %. Place a special or unusual abbreviation in parentheses after the full word or phrase the first time it appears. Use numerals to indicate numbers, except to begin sentences. Do not use subtitles, e.g., Methods, Results.
• Case Reports: Please note that “Case Reports” is its own separate topic. Case Reports submitted should be novel and should have a single, well-defined message with meaningful clinical, diagnostic or therapeutic implications adequately supported by the clinical evaluation and diagnostic tests.
• Abstract structure: Organize the abstract as follows:

• Introduction: Statement of the purpose of the study, program, project or case report.
• Methods: Statement of the methods or interventions used.
• Results: Summary of the results presented in sufficient detail to support the conclusion.
• Conclusion: Statement of the implications, conclusions reached or key message.